Lyme disease continues to rise across the United States, and with it, the number of patients struggling with lingering symptoms, misdiagnoses, and delayed treatment. For many, the path to recovery begins with choosing the best lab for Lyme disease—one that uses advanced technologies capable of detecting both early and chronic infections. TLab Diagnostics stands out as a leading choice, offering a complete suite of molecular tools built specifically for complex tick-borne illness.
Lyme disease rarely travels alone. Ticks often carry multiple pathogens, meaning a patient could have Borrelia along with Babesia, Bartonella, Ehrlichia, or other organisms. These overlapping infections can intensify symptoms and cause severe neurological, cardiac, and immune complications. This is why co-infection testing for Lyme is a core component of TLab’s diagnostic strategy. By identifying the full spectrum of pathogens, clinicians can build targeted treatment plans rather than addressing only one piece of the puzzle.
One test that has gained major clinical attention is the Bartonella FISH test. Bartonella infections are notoriously difficult to detect due to low bacterial loads and the organism’s ability to hide inside tissues. FISH (Fluorescent In Situ Hybridization) technology allows TLab to visualize Bartonella RNA directly, providing clear evidence of active infection. This level of specificity is invaluable for patients experiencing unexplained neurological symptoms, vascular inflammation, psychiatric manifestations, or chronic pain often linked to Bartonella co-infection.
Another emerging factor in long-term Lyme and co-infection cases is immune dysregulation, particularly Mast Cell Activation in Chronic Illness. Many patients dealing with chronic Lyme report symptoms such as flushing, itching, chemical sensitivities, rashes, food intolerances, and episodic inflammation. These reactions often stem from mast cells releasing excessive histamine and inflammatory mediators. TLab’s mast cell activation panels help patients and clinicians understand whether the immune system itself is contributing to their persistent symptoms.
What makes TLab Diagnostics exceptional is the integration of infection testing with immune and inflammatory assessment. Their tick-borne disease testing services include next-generation PCR, RNA-based FISH testing, DNA sequencing, inflammatory biomarkers, and mast cell activation profiles—all performed in a CAP-accredited laboratory. This ensures that results are accurate, clinically meaningful, and trusted by physicians nationwide.
For patients who feel unheard or misunderstood, advanced laboratory clarity can be life-changing. Unexplained fatigue, chronic pain, neurological issues, brain fog, night sweats, allergies, and immune system instability often point toward underlying vector-borne infections or mast cell involvement. TLab’s comprehensive panels are designed to reveal these hidden contributors and provide direction for effective treatment.
As public awareness grows around persistent Lyme disease, early detection and advanced diagnostics are more important than ever. With its specialized testing capabilities, TLab Diagnostics continues to be recognized as one of the best labs for Lyme disease, offering unmatched precision for complex, multi-system illnesses.
Summary
TLab Diagnostics provides advanced tick-borne disease testing services that make it one of the best labs for Lyme disease. Their comprehensive panels include co-infection testing for Lyme, ensuring detection of Babesia, Bartonella, and other pathogens often missed by routine testing. The highly sensitive Bartonella FISH test identifies active infection at the cellular level, supporting accurate clinical decisions. TLab also offers testing for Mast Cell Activation in Chronic Illness, a key driver of chronic symptoms in many Lyme patients. Together, these services help uncover the full picture of complex illness and guide more effective treatment strategies.
